Roche's strong U.S. presence and diversified product portfolio may mitigate the impact of potential tariffs, making it a ...

Bristol Myers Squibb has received the FDA’s green light to introduce another immunotherapy-based treatment in first-line ...

A timeline of federal higher ed changes and responses by Pittsburgh-area colleges and universities. The post Timeline: ...

The Danish biotech’s recruitment drive began last summer when data from an early-stage trial of the drug—petrelintide—showed ...

Find out what makes Basel's biotech hub so successful, as it has cemented its place as one of Europe's brightest life ...

Biocon Biologics, a subsidiary of India-based Biocon Ltd, said on Thursday that U.S. FDA has approved Jobevne, a biosimilar ...

Advertisement On the latest episode of Handbrake Off, Ian Stone, James McNicholas, Art de Roche and Amy Lawrence discussed ...

Roche has reached a significant milestone in its climate change efforts: the Science Based Targets initiative (SBTi) has ...

Investors are nervous. As of 9:55 a.m. ET Wednesday morning, shares of Roche Holding ( RHHBY -2.81%) are down 2.3%, Eli Lilly ( LLY -4.38%) stock is off 3.2%, and AstraZeneca ( AZN -4.87%) is doing ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Travere Therapeutics (TVTX – Research ...

The firm recently announced agreements with Labcorp and Quest Diagnostics to provide its devices for self-collection of vaginal swab specimens.

In a report released today, Emily Field from Barclays maintained a Hold rating on Roche Holding AG (RHHVF – Research Report), with a price ...